公司資料
Immix Biopharma 股價、新聞與催化劑
- 股票代碼:
- IMMX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
10.23 USD (-1.68%)
收盤價
最後更新: 2026年10月1日
596M USD
市值
股價為何變動
最新監測到的公司動態為「Immix Biopharma to Participate in the 45th Annual J.P. Morgan Healthcare Conference」。相應的收盤價反應尚未產生。
公司概覽
業務概覽
Immix Biopharma is a biotechnology company focused on immune-driven therapies and oncology programs. Its strategy centers on translating immune biology into targeted treatment options.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Immix sits in specialty biotechnology.
商業模式特徵
The company depends on clinical data, platform validation, and the ability to build a differentiated cancer story.
生技產業定位
Immix is a catalyst-sensitive biotech name whose stock depends on early clinical progress.
未來催化劑
- Immix’s catalysts are the oncology and immunology pipeline, especially any update that shows the company can still generate a clearer clinical path. The story remains early and data-dependent.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。